First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma
Wen, Patrick Y, Cloughesy, Timothy F, Olivero, Alan G, Morrissey, Kari M, Wilson, Timothy R, Lu, Xuyang, Mueller, Lars U, Coimbra, Alexandre F, Ellingson, Benjamin M, Gerstner, Elizabeth, Lee, Eudocia Q, Rodon, Jordi
Published in Clinical cancer research (15.04.2020)
Published in Clinical cancer research (15.04.2020)
Get full text
Journal Article
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma
Ellingson, Benjamin M, Yao, Jingwen, Raymond, Catalina, Nathanson, David A, Chakhoyan, Ararat, Simpson, Jeremy, Garner, James S, Olivero, Alan G, Mueller, Lars U, Rodon, Jordi, Gerstner, Elizabeth, Cloughesy, Timothy F, Wen, Patrick Y
Published in Clinical cancer research (01.07.2020)
Published in Clinical cancer research (01.07.2020)
Get full text
Journal Article
Overcoming reprogramming resistance of Fanconi anemia cells
Müller, Lars U.W., Milsom, Michael D., Harris, Chad E., Vyas, Rutesh, Brumme, Kristina M., Parmar, Kalindi, Moreau, Lisa A., Schambach, Axel, Park, In-Hyun, London, Wendy B., Strait, Kelly, Schlaeger, Thorsten, DeVine, Alexander L., Grassman, Elke, D'Andrea, Alan, Daley, George Q., Williams, David A.
Published in Blood (07.06.2012)
Published in Blood (07.06.2012)
Get full text
Journal Article